Gene: GPR137
Official Full Name: G protein-coupled receptor 137provided by HGNC
Gene Summary: Predicted to be involved in several processes, including negative regulation of bone resorption; negative regulation of osteoclast differentiation; and positive regulation of TORC1 signaling. Located in lysosomal membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17295 | GPR137 Knockout cell line (HeLa) | Human | GPR137 | 1:3~1:6 | Negative | Online Inquiry |
KO17296 | GPR137 Knockout cell line (HCT 116) | Human | GPR137 | 1:2~1:4 | Negative | Online Inquiry |
KO17297 | GPR137 Knockout cell line (HEK293) | Human | GPR137 | 1:3~1:6 | Negative | Online Inquiry |
KO17298 | GPR137 Knockout cell line (A549) | Human | GPR137 | 1:3~1:4 | Negative | Online Inquiry |
GPR137 gene knockout cell lines are engineered cellular models specifically designed to study the function of the GPR137 gene, which encodes a G-protein coupled receptor (GPCR) implicated in various physiological processes, including cell proliferation and signaling pathways related to cancer progression. These knockout cell lines enable researchers to explore the gene’s role by observing the effects of its absence on cellular behavior.
By utilizing CRISPR/Cas9 technology, GPR137 knockout cell lines are generated to ensure precise elimination of the target gene, allowing researchers to investigate how the absence of GPR137 alters downstream signaling mechanisms. This can elucidate its involvement in pathophysiological conditions, making the cell lines invaluable for drug discovery and therapeutic interventions, particularly in oncology. The GPR137 knockout model provides insights into GPCR-mediated signaling in various tissues, promoting an understanding of receptor interactions and the molecular underpinnings of diseases.
Significantly, these cell lines offer advantages over traditional models, such as enhanced specificity in research outcomes and the ability to create multiple variants to assess different signaling pathways. Compared to other knockouts or siRNA approaches, the stable genetic modification of GPR137 allows for consistent results across experiments. Their application can extend to screening assays for novel compounds and evaluating therapeutic efficacy or toxicity.
For researchers and clinicians, the availability of GPR137 knockout cell lines presents an exceptional opportunity to advance understanding of GPCR biology, potentially translating to improved treatment strategies. By delving into the mechanisms of this receptor, the development of targeted therapies aimed at conditions associated with GPR137 dysregulation can be expedited.
Our company specializes in providing cutting-edge biological products supported by extensive research and development, ensuring that our customers have access to reliable and innovative tools for their scientific inquiries. With a commitment to advancing biological research, we offer meticulous quality and expertise along with our GPR137 gene knockout cell lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.